EMDR in the Treatment of Specific Phobia.
Primary Purpose
Specific Phobia
Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
EMDR (Eye Movement Desensitization and Reprocessing)
Exposure therapy
Sponsored by

About this trial
This is an interventional treatment trial for Specific Phobia focused on measuring Specific (Animal) Phobia, EMDR, Exposure therapy
Eligibility Criteria
Inclusion Criteria: Patients with Specific (Animal) Phobia Exclusion Criteria: Current or past psychotic disorder Current substance dependence or abuse Serious physical illness Active suicidal behavior Bipolar affective disorder Pregnancy
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
EMDR
Arm Description
The experimental group was treated for animal phobia by EMDR, control group received an attention placebo (relaxation plus breathing exercises). Afterwards, both groups were treated by exposure therapy (therapy of choice for animal phobia).
Outcomes
Primary Outcome Measures
Behavioral Approach Test towards the feared animal.
Secondary Outcome Measures
Scores on self-report questionnaires on phobic symptoms
Neuropsychological function
Cognitive strategies
Full Information
NCT ID
NCT00184145
First Posted
September 10, 2005
Last Updated
February 24, 2017
Sponsor
Norwegian University of Science and Technology
Collaborators
St. Olavs Hospital
1. Study Identification
Unique Protocol Identification Number
NCT00184145
Brief Title
EMDR in the Treatment of Specific Phobia.
Official Title
EMDR (Eye Movement Desensitization and Reprocessing) in the Treatment of Specific Phobia. A Randomised Controlled Trial.
Study Type
Interventional
2. Study Status
Record Verification Date
February 2017
Overall Recruitment Status
Withdrawn
Why Stopped
approval of ethical committee was denied
Study Start Date
June 2004 (Actual)
Primary Completion Date
September 2004 (Actual)
Study Completion Date
September 2004 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Norwegian University of Science and Technology
Collaborators
St. Olavs Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose for this study is to determine whether EMDR is effective in the treatment of specific (animal) phobia.
Detailed Description
Aims: To test the hypothesis that one session EMDR is more effective for the treatment of specific (animal) phobia than relaxation immediately after treatment and at follow-up. Secondly to test whether an additional one-session exposure therapy offered to both treatment groups (EMDR patients and relaxation patients) improves outcome in the EMDR-group and results in equal outcome for both treatment groups.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Specific Phobia
Keywords
Specific (Animal) Phobia, EMDR, Exposure therapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
EMDR
Arm Type
Experimental
Arm Description
The experimental group was treated for animal phobia by EMDR, control group received an attention placebo (relaxation plus breathing exercises). Afterwards, both groups were treated by exposure therapy (therapy of choice for animal phobia).
Intervention Type
Other
Intervention Name(s)
EMDR (Eye Movement Desensitization and Reprocessing)
Intervention Description
Psychotherapy which is approved for PTSD.
Intervention Type
Other
Intervention Name(s)
Exposure therapy
Intervention Description
All participants in the study received exposure therapy som second treatment. Exposure therapy is the therapy of choice for animal phobia.
Primary Outcome Measure Information:
Title
Behavioral Approach Test towards the feared animal.
Time Frame
Before and after each treatment
Secondary Outcome Measure Information:
Title
Scores on self-report questionnaires on phobic symptoms
Time Frame
Before and after both treatments
Title
Neuropsychological function
Time Frame
Before first treatment, some measures also before second treatment
Title
Cognitive strategies
Time Frame
Before both treatments
10. Eligibility
Sex
All
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with Specific (Animal) Phobia
Exclusion Criteria:
Current or past psychotic disorder
Current substance dependence or abuse
Serious physical illness
Active suicidal behavior
Bipolar affective disorder
Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ludger Kaiser, Doctor
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
EMDR in the Treatment of Specific Phobia.
We'll reach out to this number within 24 hrs